An experimental MS therapy given as a nasal spray has started dosing its final participant in a Phase 2a trial of people with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results